Bv-AVEPC Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cyclophosphamide, doxorubicin, etoposide, prednisone, vincristine and brentuximab vedotin used to treat pediatric Hodgkin lymphoma (HL).

**Synonyms:** - AVE-PC-Brentuximab Vedotin Regimen - AVEPC-Adcetris - AVEPC-Adcetris Regimen - AVEPC-Brentuximab Vedotin - Adcetris-Cyclophosphamide/Doxorubicin//Etoposide/Prednisone/Vincristine - BV-AVE-PC Regimen - BV-AVEPC - Brentuximab Vedotin with AVE-PC - Brentuximab Vedotin with AVEPC Regimen - Brentuximab Vedotin/Adriamycin/Vincristine/Etoposide/Prednisone/Cyclophosphamide - Brentuximab Vedotin/Cyclophosphamide/Doxorubicin//Etoposide/Prednisone/Vincristine - Brentuximab Vedotin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine Regimen - Brentuximab Vedotin/Doxorubicin/Vincristine/Etoposide/Prednisone/Cyclophosphamide - Bv-AVEPC - Bv-AVEPC - Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone-Etoposide/Brentuximab Vedotin Regimen - Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine/Brentuximab Vedotin